| 영문 | cancer chemotherapy | 한글 | 항암화학요법 |
|---|---|---|---|
| 설명 | 화학적 물질을 이용하여 암을 치료하는 것을 말한다. 이때 사용되는 물질을 항암제라고 한다. 이상적인 항암제는 정상적인 세포에는 이상이 없고 단지 암세포에만 치명적인 효과를 나타내어야 한다. 이렇게 하려면 암세포만의 특이한 특성을 이해하고 그곳에만 작용하는 약물을 개발하여야 한다. 최근 대부분의 항암제는 암세포가 정상 세포에 비하여 월등히 증식을 빨리한다는 특성을 이용하고 있다. 증식이 빠르다는 것은 유전정보를 가지고 있는 DNA의 복제가 빠르다는 것을 의미한다. 만약 DNA의 복제를 방해한다면 증식이 아주 빠른 암세포에게는 치명적이지만 영원히 증식을 하지 않는(DNA의 복제가 거의 필요없는)신경세포나 증식이 암세포에 비해서 아주 느린 정상세포에서는 거의 영향을 주지 못한다. 하지만 신체에서도 정상적으로 증식이 암세포와 비슷한 수준으로 일어나는 세포가 있는데 그것은 머리카락을 만드는 모낭세포와 소화관의 점막을 이루는 세포와 혈액의 세포를 만드는 골수 세포이다. 그러므로 항암제를 사용할 경우 이런 세포가 암세포와 마찬가지로 치명적인 영향을 입을 것은 당연하다(그래서 항암제 치료시엔 머리가 빠지고 소화불량이 잘온다). |
||
| 영문 | chemotherapy | 한글 | 화학요법 |
|---|---|---|---|
| 설명 | 화학적 물질로 병을 치료하는 것을 말한다. 워낙 세균감염을 치료하는 방법으로 주로 사용되었으나 요지음에 와서는 암을 치료하는 방법으로 더 많이 쓰이고 있다. |
||
| SCC | self-care center; sequential combination chemotherapy; services for crippled children; short-course ... |
|---|---|
| SVA | selective vagotomy and antrectomy; selective visceral angiography; sequential ventriculoatrial [paci... |
| BM | Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra... |
| MMR | mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella... |
| CTx | Chemotherapy |
| LV mass | Left ventricular mass |
|---|---|
| MS/MS | mass spectrometry and -tandem mass spectrometry |
| CHOP | Chemotherapy |
| CHT | Chemotherapy |
| CT | Chemotherapy |
| adjuvant chemotherapy | <oncology, pharmacology> Chemotherapy treatment that is given as an add-on to their primary cancer treatment, as in surgery or radiation therapy. (16 Dec 1997) |
|---|---|
| remission induction chemotherapy | The initial chemotherapy a patient receives to bring about a remission. (12 Dec 1998) |
| chemotherapy | <pharmacology, oncology> The treatment of disease by means of chemicals that have a specific toxic effect upon the disease producing microorganisms (antibiotics) or that selectively destroy cancerous tissue (anticancer therapy). (12 May 1997) |
| chemotherapy, adjuvant | Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. (12 Dec 1998) |
| chemotherapy drug sensitivity test | <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful. (16 Dec 1997) |
| combination chemotherapy | <oncology> Treatment consisting of the use of two or more chemicals to achieve maximum kill of tumour cells. (09 Jan 1998) |
| consolidation chemotherapy | Repetitive cycles of treatment during the immediate post-remission period, used especially for leukaemia. Synonym: intensification chemotherapy. (05 Mar 2000) |
| salvage chemotherapy | Use of chemotherapy in a patient with recurrence of a malignancy following initial treatment, in hope of a cure or prolongation of life. Synonym: salvage therapy. (05 Mar 2000) |
| second line chemotherapy | <oncology> Chemotherapy given for a tumour which has already failed to respond to a first chemotherapy regimen (called first line). (16 Dec 1997) |
| selective angiography | <procedure, radiology> Angiography in which visualization is improved by concentrating the contrast medium in the region to be studied by injection through a catheter positioned in a regional artery. (05 Mar 2000) |
| selective grinding | <dentistry> The modification of the occlusal forms of teeth by grinding according to a plan or by grinding at selected places marked by articulating ribbon or paper. (05 Mar 2000) |
| selective hypoaldosteronism | <endocrinology> Isolated hypoaldosteronism, aldosterone deficiency without a concomitant deficiency of glucocorticoid hormones. (05 Mar 2000) |
| selective immunoglobulin A deficiency | <immunology> An inherited disorder in which there is a markedly reduced or absent IgA, resulting in immature IgA-bearing B-cells. (05 Mar 2000) |
| selective inhibition | <chemistry> Inhibitor that occupies the active site of an enzyme or the binding site of a receptor and prevents the normal substrate or ligand from binding. at sufficiently high concentration of the normal ligand inhibition is lost: the Km is altered by the competitive inhibitor, but the Vmax remains the same. (05 Jan 1998) |
| selective injection | Injection of contrast medium following selective catheterization of a branch artery or vein for angiography. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|